Volume | 2,527,524 |
|
|||||
News | - | ||||||
Day High | 220.00 | Low High |
|||||
Day Low | 215.68 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Danaher Corporation | DHR | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
219.00 | 215.68 | 220.00 | 217.49 | 218.92 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
45,438 | 2,527,524 | US$ 217.55 | US$ 549,861,330 | - | 182.09 - 281.535 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:39:41 | 1 | US$ 217.21 | USD |
Danaher (DHR) Options Flow Summary
Danaher Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
160.71B | 738.93M | - | 31.47B | 7.1B | 9.61 | 22.63 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Danaher News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DHR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 222.51 | 223.79 | 215.68 | 220.99 | 2,546,294 | -4.90 | -2.2% |
1 Month | 195.86 | 225.36 | 192.345 | 215.09 | 2,707,198 | 21.75 | 11.11% |
3 Months | 252.19 | 260.07 | 182.09 | 213.52 | 3,118,297 | -34.58 | -13.71% |
6 Months | 237.52 | 269.61 | 182.09 | 231.05 | 2,909,076 | -19.91 | -8.38% |
1 Year | 268.79 | 281.535 | 182.09 | 239.90 | 2,865,800 | -51.18 | -19.04% |
3 Years | 225.35 | 333.96 | 182.09 | 258.87 | 2,640,104 | -7.74 | -3.43% |
5 Years | 101.69 | 333.96 | 94.15 | 207.30 | 3,082,567 | 115.92 | 114.0% |
Danaher Description
Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment. |